Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps

View through CrossRef
Persistent infection with hepatitis D virus (HDV), also known as hepatitis delta, is considered the most severe form of chronic viral hepatitis. HDV is a defective RNA virus that depends on hepatitis B virus (HBV) for propagation. Despite its global distribution, HDV stays a neglected part of the viral hepatitis agenda, often overlooked in surveillance systems and public health policy. This oversight is particularly concerning given HDV’s aggressive clinical course, characterized by more rapid progression to cirrhosis, liver failure, and hepatocellular carcinoma (HCC) compared to HBV mono-infection. Mongolia has the highest incidence and mortality rates of HCC worldwide, with approximately 47% of cases estimated to be attributable to chronic HDV infection. Globally, an estimated 12–25 million people are co-infected with HBV and HDV, although the true prevalence is higher due to insufficient screening and incomplete data collection. Because HDV infection is entirely dependent on HBV, prevention of HBV infection through effective vaccination stands for an indirect yet highly effective strategy to curb HDV transmission. The World Health Organization (WHO), together with the global health community, has established ambitious targets to eliminate viral hepatitis as a public health threat by 2030. However, achieving HDV elimination remains particularly challenging due to limited diagnostic capacity, low awareness, and minimal inclusion of HDV in national hepatitis programs. This review explores the intersection of HDV and HBV, focusing on how expanded and optimized HBV vaccination coverage can serve as a cornerstone of global HDV prevention efforts. We examine epidemiological evidence, scientific rationale, policy developments, and key implementation challenges, with particular attention to high-burden settings such as Mongolia. Finally, we propose strategic recommendations to bridge policy and practice gaps in HDV elimination.
Title: Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps
Description:
Persistent infection with hepatitis D virus (HDV), also known as hepatitis delta, is considered the most severe form of chronic viral hepatitis.
HDV is a defective RNA virus that depends on hepatitis B virus (HBV) for propagation.
Despite its global distribution, HDV stays a neglected part of the viral hepatitis agenda, often overlooked in surveillance systems and public health policy.
This oversight is particularly concerning given HDV’s aggressive clinical course, characterized by more rapid progression to cirrhosis, liver failure, and hepatocellular carcinoma (HCC) compared to HBV mono-infection.
Mongolia has the highest incidence and mortality rates of HCC worldwide, with approximately 47% of cases estimated to be attributable to chronic HDV infection.
Globally, an estimated 12–25 million people are co-infected with HBV and HDV, although the true prevalence is higher due to insufficient screening and incomplete data collection.
Because HDV infection is entirely dependent on HBV, prevention of HBV infection through effective vaccination stands for an indirect yet highly effective strategy to curb HDV transmission.
The World Health Organization (WHO), together with the global health community, has established ambitious targets to eliminate viral hepatitis as a public health threat by 2030.
However, achieving HDV elimination remains particularly challenging due to limited diagnostic capacity, low awareness, and minimal inclusion of HDV in national hepatitis programs.
This review explores the intersection of HDV and HBV, focusing on how expanded and optimized HBV vaccination coverage can serve as a cornerstone of global HDV prevention efforts.
We examine epidemiological evidence, scientific rationale, policy developments, and key implementation challenges, with particular attention to high-burden settings such as Mongolia.
Finally, we propose strategic recommendations to bridge policy and practice gaps in HDV elimination.

Related Results

Hepatitis D seroprevalence: An alarming situation and war without weapon.
Hepatitis D seroprevalence: An alarming situation and war without weapon.
Objective: To determine the seroprevalence of HDV in HBs Ag positive patients and the burden of true viral hepatitis infection (viremia) as evidenced by detectable either HBV DNA a...
Profil virologique et immunologique des patients atteints d'hépatite chronique B et Delta en Gambie
Profil virologique et immunologique des patients atteints d'hépatite chronique B et Delta en Gambie
L'infection par le virus de l'hépatite B (VHB) est un problème de santé publique. Actuellement, plus de 254 millions de personnes sont chroniquement infectées, dont 65 % vivent en ...
Modulation of HBV infection and replication by cell-derived factors
Modulation of HBV infection and replication by cell-derived factors
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT REQUEST OF AUTHOR.] Hepatitis B virus (HBV) infection is one of the most serious health problems. HBV infection leads to serious...
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic
Hepatitis delta virus RNA decline post inoculation in human NTCP transgenic mice is biphasic
ABSTRACT Background and Aims Chronic infection with hepatitis B and hepatitis delta viruses (HDV) is considered the most seriou...
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
Hepatitis delta virus RNA decline post-inoculation in human NTCP transgenic mice is biphasic
ABSTRACT Chronic infection with hepatitis B and delta viruses (HDV) is the most serious form of viral hepatitis due to more severe manifestations of an accelerate...
True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach
True prevalence of twin HDV-HBV infection in Pakistan: a molecular approach
Abstract Hepatitis Delta Virus (HDV) infects only patients that are already infected by hepatitis B virus (HBV) because this is sub satellite virus which depends on and p...

Back to Top